Fostamatinib disodium (R935788)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Fostamatinib disodium (R935788), covering 2012-08-29 to 2012-08-29. Get the full timeline:
Most recent: Clinical Trial Update: A Broad Multi-histology Phase II Study of the Multi-Kinase Inhibitor R935788 (Fostamatinib Disodium) in Advanced Colorectal, Non-small Cell Lung, Head and Neck Hepatocellular and Renal Cell Carcinomas, and Pheochromocytoma and Thyroid Tumors (Multi-H... [Phase 2]